Cargando…
Application of Purified Botulinum Type A Neurotoxin to Treat Experimental Trigeminal Neuropathy in Rats and Patients with Urinary Incontinence and Prostatic Hyperplasia
Type A neurotoxin (NTX) of Clostridium botulinum was purified by a simple procedure using a lactose gel column. The toxicity of this purified toxin preparation was retained for at least 1 year at −30°C by supplementation with either 0.1% albumin or 0.05% albumin plus 1% trehalose. When purified NTX...
Autores principales: | Matsuka, Yoshizo, Yokoyama, Teruhiko, Yamamoto, Yumiko, Suzuki, Tomonori, Dwi Fatmawati, Ni Nengah, Nishikawa, Atsushi, Ohyama, Tohru, Watanabe, Toshihiro, Kuboki, Takuo, Nagai, Atsushi, Oguma, Keiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382382/ https://www.ncbi.nlm.nih.gov/pubmed/22745637 http://dx.doi.org/10.1155/2012/648384 |
Ejemplares similares
-
Peripherally Administered Botulinum Toxin Type A Localizes Bilaterally in Trigeminal Ganglia of Animal Model
por: Waskitho, Arief, et al.
Publicado: (2021) -
Cross-Excitation in Peripheral Sensory Ganglia Associated with Pain Transmission
por: Omoto, Katsuhiro, et al.
Publicado: (2015) -
Antinociceptive Effects of Transcytosed Botulinum Neurotoxin Type A on Trigeminal Nociception in Rats
por: Kim, Hye-Jin, et al.
Publicado: (2015) -
Botulinum neurotoxin type A for the treatment of pain: not just in migraine and trigeminal neuralgia
por: Sandrini, Giorgio, et al.
Publicado: (2017) -
Modulation of inflammatory mediators in the trigeminal ganglion by botulinum neurotoxin type A: an organ culture study
por: Edvinsson, Jacob, et al.
Publicado: (2015)